Medical School News and Research

RSS

Two new studies show how to enhance effectiveness of cancer immunotherapy

Two new studies revealed that anti-PD-1 immunotherapy given before surgery was safe and effective for patients with oral-cavity squamous cell carcinoma (OCSCC) and identified potential molecular biomarkers in the blood and tumors of patients that would show how likely it is that someone would respond to immunotherapy.

30 Oct 2021

Alzheimer's disease develops in a very different way than previously thought

For the first time, researchers have used human data to quantify the speed of different processes that lead to Alzheimer's disease and found that it develops in a very different way than previously thought.

30 Oct 2021

Scientists develop new approach to combat treatment-resistant melanoma

Researchers from the Centenary Institute have developed a new approach to fighting melanomas that fail to respond – or are resistant – to standard treatments. The deadliest form of skin cancer, melanoma is responsible for more than 1,700 deaths each year in Australia.

30 Oct 2021

Therapeutic heparin for preventing COVID-19 deaths is four times higher than the prophylactic dose

The anti-coagulant heparin reduces the likelihood of death from COVID-19 by 78% when administered in therapeutic doses to patients with signs of respiratory failure on admission to hospital, according to a study reported on October 14 in the British Medical Journal.

30 Oct 2021

Researchers discover potential new Covid-19 treatment

Researchers have identified a potential new treatment that suppresses the replication of SARS-CoV-2, the coronavirus that causes Covid-19.

30 Oct 2021

Prompt procurement and rapid pace of vaccination likely to have a greater impact than vaccine efficacy

For low- and middle-income countries, a COVID-19 vaccination program built on prompt procurement, effective on-the-ground distribution, and a rapid pace of vaccination (the total number of doses given daily) is likely to have a greater public health impact than one focused on relatively small differences in vaccine efficacy, according to a study led by researchers at Massachusetts General Hospital.

30 Oct 2021

Study: mRNA vaccines associated with more immunity than prior COVID-19 infection

A nationwide study from the Centers for Disease Control and Prevention shows that mRNA COVID-19 vaccines are associated with significantly more immunity than a prior COVID-19 infection.

29 Oct 2021

New evidence that SARS-CoV-2 virus can infect the inner ear

Many Covid-19 patients have reported symptoms affecting the ears, including hearing loss and tinnitus. Dizziness and balance problems can also occur, suggesting that the SARS-CoV-2 virus may be able to infect the inner ear.

29 Oct 2021

Researchers develop eToeholds for safe, effective RNA and cellular therapies

RNAs are best known as the molecules that translate information encoded in genes into proteins with their myriad of activities.

29 Oct 2021

Scientists uncover key genetic networks governing human embryonic stem cell behavior

At the earliest stages of human embryonic development, a small collection of cells known as human embryonic stem cells (hESCs) orchestrates growth and differentiation, eventually giving rise to highly specialized human tissues.

28 Oct 2021

Combining clinical and EEG factors can help better predict treatment response in epilepsy patients

Combining electroencephalogram (EEG) data with clinical observations can help doctors to better determine whether generalized epilepsy patients will respond to treatment, according to a study led by Rutgers researchers.

28 Oct 2021

Study: Younger and older patients with metastatic colorectal cancer survive for same amount of time

Even though young patients with metastatic colorectal cancer tend to be more fit and receive more intensive treatment than older patients, both groups survive for roughly the same amount of time, according to a new study by Dana-Farber Cancer Institute investigators.

27 Oct 2021

Promising new therapy for mesothelioma to enter a Phase I clinical trial

Linked to occupational asbestos exposure, malignant mesothelioma (MM) is an aggressive cancer arising primarily from the outer lining of the lungs with a dismal five-year survival rate of only five to 10 percent.

27 Oct 2021

Study finds disparities in dissemination of cancer survivorship care plans

Survivorship care plans are an important tool to help cancer survivors transition out of active treatment and back to their regular lives, but a new study found that a number of vulnerable groups are not receiving those plans.

27 Oct 2021

SARS-CoV-2 infection leads to greater risk of neurological complications than vaccines

Researchers from across the UK, led by the University of Oxford, have today reported on the risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.

27 Oct 2021

New study explains why Delta is so easily transmitted and infects people quickly

The Delta variant of SARS-CoV-2 has swept the globe, becoming the dominant variant within just a few months. A new study from Boston Children's Hospital, published today in Science, explains why Delta is so easily spread and infects people so quickly, and suggests a more targeted strategy for developing future COVID-19 vaccines and treatments.

27 Oct 2021

HCV treatment decreases protein activity levels involved in liver cirrhosis, research shows

Researchers at the Medical University of South Carolina report in the Journal of Viral Hepatitis that the activity levels of the proteins involved in liver scarring, or cirrhosis, begin to decrease immediately after treatment for the hepatitis C virus (HCV), suggesting the possibility of early healing.

26 Oct 2021

Lung cancer-associated fibroblasts could guide the design of personalized treatments

Three subtypes of cancer-associated fibroblasts (CAF) could guide the design of personalized treatment for lung cancer patients, according to a new study in Cancer Cell led by researchers at Massachusetts General Hospital.

26 Oct 2021

New education programs aim to address the gaps in public health workforce capacity

UMass Lowell has been awarded a $3 million cooperative agreement from the U.S. Department of Health and Human Services' Office of the National Coordinator for Health Information Technology to develop new undergraduate and graduate programs in public health informatics and technology, to educate diverse students for vital jobs.

26 Oct 2021

Safer, more effective therapies could help fight the obesity epidemic

Novel obesity treatments such as modulation of the gut microbiome and gene therapy are underutilized and could help fight the obesity epidemic, according to a new manuscript published in the Endocrine Society's journal, Endocrine Reviews.

26 Oct 2021

Medical School News and Research

Two new studies show how to enhance effectiveness of cancer immunotherapy

Alzheimer's disease develops in a very different way than previously thought

Scientists develop new approach to combat treatment-resistant melanoma

Therapeutic heparin for preventing COVID-19 deaths is four times higher than the prophylactic dose

Researchers discover potential new Covid-19 treatment

Prompt procurement and rapid pace of vaccination likely to have a greater impact than vaccine efficacy

Study: mRNA vaccines associated with more immunity than prior COVID-19 infection

New evidence that SARS-CoV-2 virus can infect the inner ear

Researchers develop eToeholds for safe, effective RNA and cellular therapies

Scientists uncover key genetic networks governing human embryonic stem cell behavior

Combining clinical and EEG factors can help better predict treatment response in epilepsy patients

Study: Younger and older patients with metastatic colorectal cancer survive for same amount of time

Promising new therapy for mesothelioma to enter a Phase I clinical trial

Study finds disparities in dissemination of cancer survivorship care plans

SARS-CoV-2 infection leads to greater risk of neurological complications than vaccines

New study explains why Delta is so easily transmitted and infects people quickly

HCV treatment decreases protein activity levels involved in liver cirrhosis, research shows

Lung cancer-associated fibroblasts could guide the design of personalized treatments

New education programs aim to address the gaps in public health workforce capacity

Safer, more effective therapies could help fight the obesity epidemic

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News